Brandstetter H, Grams F, Glitz D, Lang A, Huber R, Bode W, Krell H W, Engh R A
Department of Structural Research, Max Planck Institute for Biochemistry, D-82152 Martinsried, Germany.
J Biol Chem. 2001 May 18;276(20):17405-12. doi: 10.1074/jbc.M007475200. Epub 2001 Jan 22.
The individual zinc endoproteinases of the tissue degrading matrix metalloproteinase (MMP) family share a common catalytic architecture but are differentiated with respect to substrate specificity, localization, and activation. Variation in domain structure and more subtle structural differences control their characteristic specificity profiles for substrates from among four distinct classes (Nagase, H., and Woessner, J. F. J. (1999) J. Biol. Chem. 274, 21491-21494). Exploitation of these differences may be decisive for the design of anticancer or other drugs, which should be highly selective for their particular MMP targets. Based on the 1.8-A crystal structure of human neutrophil collagenase (MMP-8) in complex with an active site-directed inhibitor (RO200-1770), we identify and describe new structural determinants for substrate and inhibitor recognition in addition to the primary substrate recognition sites. RO200-1770 induces a major rearrangement at a position relevant to substrate recognition near the MMP-8 active site (Ala206-Asn218). In stromelysin (MMP-3), competing stabilizing interactions at the analogous segment hinder a similar rearrangement, consistent with kinetic profiling of several MMPs. Despite the apparent dissimilarity of the inhibitors, the central 2-hydroxypyrimidine-4,6-dione (barbiturate) ring of the inhibitor RO200-1770 mimics the interactions of the hydroxamate-derived inhibitor batimastat (Grams, F., Reinemer, P., Powers, J. C., Kleine, T., Pieper, M., Tschesche, H., Huber, R., and Bode, W. (1995) Eur. J. Biochem. 228, 830-841) for binding to MMP-8. The two additional phenyl and piperidyl ring substituents of the inhibitor bind into the S1' and S2' pockets of MMP-8, respectively. The crystal lattice contains a hydrogen bond between the O(gamma) group of Ser209 and N(delta)1 of His207 of a symmetry related molecule; this interaction suggests a model for recognition of hydroxyprolines present in physiological substrates. We also identify a collagenase-characteristic cis-peptide bond, Asn188-Tyr189, on a loop essential for collagenolytic activity. The sequence conservation pattern at this position marks this cis-peptide bond as a determinant for triple-helical collagen recognition and processing.
组织降解基质金属蛋白酶(MMP)家族中的各个锌内蛋白酶具有共同的催化结构,但在底物特异性、定位和激活方面存在差异。结构域结构的变化以及更细微的结构差异控制着它们对四类不同底物(长濑浩和沃斯纳,J.F.J.(1999年)《生物化学杂志》274卷,21491 - 21494页)的特征性特异性谱。利用这些差异对于抗癌或其他药物的设计可能具有决定性作用,这些药物应对其特定的MMP靶点具有高度选择性。基于人中性粒细胞胶原酶(MMP - 8)与活性位点导向抑制剂(RO200 - 1770)复合物的1.8埃晶体结构,我们除了确定主要底物识别位点外,还识别并描述了底物和抑制剂识别的新结构决定因素。RO200 - 1770在MMP - 8活性位点(Ala206 - Asn218)附近与底物识别相关的位置诱导了重大重排。在基质溶解素(MMP - 3)中,类似片段处的竞争性稳定相互作用阻碍了类似的重排,这与几种MMP的动力学分析结果一致。尽管抑制剂表面上不同,但抑制剂RO200 - 1770的中心2 - 羟基嘧啶 - 4,6 - 二酮(巴比妥酸)环模拟了异羟肟酸衍生抑制剂batimastat(格拉姆斯,F.,赖内默,P.,鲍尔斯,J.C.,克莱内,T.,皮珀,M., 切舍,H., 胡贝尔,R.和博德,W.(1995年)《欧洲生物化学杂志》228卷,830 - 841页)与MMP - 8结合的相互作用。抑制剂的另外两个苯基和哌啶基环取代基分别结合到MMP - 8的S1'和S2'口袋中。晶格中对称相关分子的Ser209的O(γ)基团与His207的N(δ)1之间存在氢键;这种相互作用提示了一种识别生理底物中羟脯氨酸的模型。我们还在对胶原分解活性至关重要的环上确定了一个胶原酶特征性的顺式肽键Asn188 - Tyr189。该位置的序列保守模式将这个顺式肽键标记为三螺旋胶原识别和加工的决定因素。